Danby Research Grant, Translational Research Grant, and Mentored Experience Grant

Danby Research Grant, Translational Research Grant, and Mentored Experience Grant are grant programs from the Hidradenitis Suppurativa Foundation (HSF) that fund clinical and translational research into hidradenitis suppurativa (HS). Up to four grants may be awarded per year, with individual Danby Research Grants providing up to $30,000 for one-year projects. HSF also offers larger awards up to $100,000 for qualified applicants.

Projects must be conducted by U.S.-based investigators and aim to advance patient care through new clinical and translational lines of investigation in HS. Priority is given to early-stage investigators and research teams with diverse composition. Applications are reviewed based on relevance to HS, scientific rigor, investigator ability, and potential to attract additional funding.

HSF Danby Research Grant Program Request for Proposals - CLOSED Application deadline: December 8, 2025 at midnight Notification: March, 2026 @ AAD Annual Meeting Project Period: June 1, 2026 – May 31, 2027 The Hidradenitis Suppurativa Foundation (HSF) is seeking grant applications that encourage research into the disease hidradenitis suppurativa (HS).

The goal is the development of new clinical and translational lines of investigation in the field of HS that further patient care. Anticipated number of awards Four grants may be awarded each year. Awards are contingent upon the availability of funds and the receipt of sufficiently meritorious applications.

Applicants may request up to $30,000 per year (direct costs only). All funds are to be spent within the one year project period. The application must be submitted via the portal link highlighted above and the application should follow the format outlined below.

The principal investigator must be personally and actively responsible for the conduct of the proposed research, and eligible to apply for research grants under the guidelines of the applicant’s host institution. Only investigators working in the United States are eligible to apply. Early-stage investigators will be given priority.

The HSF does not fund projects that are part of the NIH intramural research program, nor offers awards to private foundations without an academic affiliation to dermatology. Reviewers will be asked to base their evaluations on the criteria listed below.

Relevance to hidradenitis suppurativa Strategy, methodology and analyses are well-reasoned and appropriate to accomplish the aims Ability of investigator to accomplish aims Potential problems, alternative strategies, and benchmarks for success are presented Diversity of the research team and the patient cohort planned for study Likelihood of leading to additional funding, and/or findings to directly impact patient care and/or raise disease awareness Within 60 days of completing the approved project, the grantee is required to submit a written report summarizing their research experience and findings.

The grantee should also present the work at the annual scientific meeting of the HSF, the Symposium on Hidradenitis Suppurativa Advances (SHSA), or another national or international conference within two years of funding. Presenting at the SHSA does not preclude presenting at another national or international meeting, as the SHSA permits simultaneous submission of the same abstract to other meetings.

If an approved project cannot be completed as originally proposed or within the time limits mandated, the grantee must immediately contact the HSF. Upon Successful Application: Awardees will be asked to submit a headshot to be used to announce the successful applicants. Hidradenitis Suppurativa Foundation Danby Research Grant Application The application should follow the following format, with a minimum of 0.

5 inch margins and minimum of 11-point Arial font, single spaced. A. TITLE PAGE : Include the grant title, principal investigator’s name, and affiliations.

B. ABSTRACT : Summarize the proposed research for a scientific audience. Abstract must not exceed 350 words.

C. LAYMAN’S STATEMENT : Summarize the proposed research for a non-scientific audience. This statement should describe the research question, the aims of the project, and the project’s significance with respect to HS.

Layman’s statement must not exceed 200 words. D. BUDGET : Each grant is up to $30,000 for one year.

Indirect costs are not allowed. Provide a budget summary, including a concise statement of how you propose to allocate funds (amount and for what purpose). Award may be used to provide salary support for PI or other staff.

List all personnel to be included in the project and their anticipated support. Travel and publication costs are not allowed. E.

BIOGRAPHICAL SKETCH(ES) : Use the NIH format to provide a biographical sketch of the proposal’s principal investigator and any co-investigators who will play a significant role on the project. Each biographical sketch must not exceed five (5) pages. F.

LETTER(S) OF SUPPORT : Applicants may include letters of support from collaborators or supporting people/facilities/resources who will contribute to the proposed research. If the applicant is a postdoctoral fellow, a letter of support from the applicant’s immediate supervisor must be provided. G.

RESEARCH PROPOSAL : Research proposals must include the following five sections, maximum two (2) pages, singled spaced, 0. 5 inch margins, Arial 11 font: Specific aims: The goals of this one-year proposal should be succinctly stated. What hypothesis is to be tested?

What do you intend to accomplish? Background and significance: Why is the research important? Evaluate existing knowledge in the field and specifically identify the possible contributions that your investigation may make.

Preliminary data/studies: Describe published or unpublished data that support your hypothesis, specific aims and/or experimental design. Experiment design: Describe the experimental design, the procedures to be used, and the data analysis plan. Descriptions of established lab procedures are not necessary.

Future directions should also be indicated. Proposed Impact: Describe how findings from this study will impact patient care. H.

REFERENCES : List of references cited. I. HUMAN SUBJECT PROTECTION : Describe samples, risks, adequacy of protection against risks, and potential benefit.

Applications related to research on human subjects must be approved by the institutional review board prior to the initiation of successful awards. J. ANIMAL STUDIES : Applications that involve research on animals must demonstrate their relevance to clinical dermatology.

Application involving animal studies must be approved by an appropriate institutional committee prior to the initiation of successful awards.